Skip to content

uniQure QURE Total Revenue

Total Revenue at other companies

Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$136M-2.2%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$272.55M-76.8%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$1.46M+68.6%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$116.36M+31.9%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$194.52M+66.8%
ALN
Alnylam PharmaceuticalsALNY
$1.17B+96.4%

Segments

By segment

See full
Single Reportable$3.56M+127%

Other financials

Income statement

See full
Gross profit$3.3M+144%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Market cap$3.09B+78.4%
Enterprise value$3.02B+124%
P/S170.9×+85.1×

Profitability

See full
Gross margin90.6%-2.9pp
Operating margin-1,059.7%+380pp
Net margin-1,154.4%+89.3pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's total revenue?
uniQure (QURE) reported total revenue of $3.56M in Q1 2026.
How has uniQure's total revenue changed year-over-year?
uniQure's total revenue increased by 127.3% year-over-year, from $1.57M to $3.56M.
What is the long-term trend for uniQure's total revenue?
Over 4 years (2021 to 2025), uniQure's total revenue has grown at a -58.1% compound annual growth rate (CAGR), from $524M to $16.1M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.